A quiet but growing threat: Global perspectives on antifungal resistance and future therapeutic approaches. [PDF]
Gurajala S, Challapilla M.
europepmc +1 more source
Susceptibility of Candida auris isolates to antifungal agents: perspectives from whole-genome sequencing and phenotypic testing. [PDF]
Xie Z, Li Y, Yang F, Liu W, Cai R, Lu Y.
europepmc +1 more source
Preliminary Functional Screening of Autochthonous <i>Saccharomyces cerevisiae</i> from Mexican Cocoa Bean Fermentation for Traits Associated with Probiotic Potential. [PDF]
López-Palestino A +8 more
europepmc +1 more source
Natural-Compound Adjuvants Dismantle Candida Biofilms: Mechanisms, Design Rules, and Biofilm-Aware Pharmacology. [PDF]
Tuan DA, Masak J.
europepmc +1 more source
Diagnosis, treatment, and biosafety protection of imported highly pathogenic cutaneous fungal infection: a case-based study of cutaneous coccidioidomycosis. [PDF]
Weng Y, Liu Z, Xia X.
europepmc +1 more source
Clinical <i>Talaromyces marneffei</i> isolates exhibit enhanced stress tolerance and diminished antifungal responsiveness relative to non-clinical strains. [PDF]
Pan KS +5 more
europepmc +1 more source
Antifungal susceptibility, FKS1 gene expression, and virulence determinants of Candida albicans in pediatric and neonatal candidiasis. [PDF]
Rezaei-Mojaz M +7 more
europepmc +1 more source
<i>In silico</i> identification of isosilybin a targeting squalene epoxidase as an antifungal adjuvant with <i>in vitro</i> validation against azole-resistant <i>Candida</i> and emerging yeasts. [PDF]
Mundhe AK, Rajkumari R.
europepmc +1 more source
Micafungin microevolution in <i>Candida auris</i> reveals resistance development without <i>in vivo</i> fitness compromise. [PDF]
Bohner F +5 more
europepmc +1 more source
Iron modulation drives biofilm formation and virulence enzyme production in emerging clinical <i>Candida</i> species: implications for diagnostics and therapeutics. [PDF]
Kumari S +6 more
europepmc +1 more source

